Alvotech (ALVO) EBIT Margin (2022 - 2026)
Alvotech (ALVO) reported EBIT Margin of -134.08% for Q2 2026, down 124.85 percentage points from -9.22% a year earlier and down 152.98 percentage points from the prior quarter.
Powered by 
Analysis
Alvotech (ALVO) EBIT Margin (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Alvotech's EBIT Margin came in at -60.17%, down 55.01 percentage points year-over-year; for FY2025, it came in at 28.31%, up 133.33 percentage points from FY2024.
- EBIT Margin has increased for three consecutive years, with a five-year change of +234.77 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -105.02% in FY2024 (+623.66 pp), -728.68% in FY2023 (+666.24 pp) and -1394.92% in FY2022.
- Five-year quarterly EBIT Margin spans a low of -5177.62% in Q3 2022 and a high of 2170.00% in Q2 2023.
- Year over year, EBIT Margin gained in three of the last six quarters, with an average year-over-year change of +142.59 percentage points.
- The high point for year-over-year EBIT Margin in five years was Q3 2023 (a gain of 4345.13 percentage points); the low point was Q2 2024 (a drop of 2438.13 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Alvotech | 1.85 Bn | 1.41 Bn | 2.56 Mn | -134.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -134.08% |
| Mar 31, 2026 | 18.90% |
| Sep 30, 2025 | -929.24% |
| Jun 30, 2025 | -9.22% |
| Mar 31, 2025 | 75.37% |
| Dec 31, 2024 | -236.07% |
| Sep 30, 2024 | 399.30% |
| Jun 30, 2024 | -268.13% |
| Mar 31, 2024 | -389.53% |
| Dec 31, 2023 | -1,877.67% |
| Sep 30, 2023 | -4,659.15% |
| Jun 30, 2023 | 2,170.00% |
| Dec 31, 2022 | -2,514.82% |
| Jun 30, 2022 | 412.31% |
API Access
Alvotech EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ALVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();